Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Yaacov Goykhman"'
Autor:
Esther Osher, Ravit Geva, Ido Wolf, Karen Tordjman, Joseph Klausner, Yael Sofer, Erez Scapa, Oren Shibolet, Dana Ben –Ami Shor, Iddo Bar-Yishay, Nir Lubezky, Yaacov Goykhman, Guy Lahat, Oz Yakir, Sharon Pelles, Asaf Aizic, Arye Blachar, Naftali Stern, Yona Greenman
Publikováno v:
Journal of Clinical & Translational Endocrinology, Vol 33, Iss , Pp 100322- (2023)
Objective: Pancreatic neuroendocrine tumors (PNETs) are rare, but their incidence has risen significantly in recent years. Whereas diabetes mellitus (DM) is recognized in association with chronic pancreatitis and pancreatic cancer, it has not been we
Externí odkaz:
https://doaj.org/article/682c3f76a41c447cba9291adbede8aa8
Autor:
Yossi Maman, Yaacov Goykhman, Oz Yakir, Alex Barenboim, Ravit Geva, Sharon Peles-Avraham, Ido Wolf, Joseph M. Klausner, Guy Lahat, Nir Lubezky
Publikováno v:
Cancers, Vol 15, Iss 11, p 3049 (2023)
Background: The recommended treatment for resectable pancreatic cancer (PC) is resection followed by adjuvant FOLFIRINOX. We assessed the proportion of patients that managed to complete the 12 courses of adjuvant FOLFIRINOX and compared their outcome
Externí odkaz:
https://doaj.org/article/05baf72f065a4e4db23db59fab37f5ea
Autor:
Esther Osher, Eiman Shalabna, Joseph M. Klausner, Yona Greenman, Naftali Stern, Oren Shibolet, Erez Scapa, Oz Yakir, Dana Ben-Ami Shor, Iddo Bar-Yishay, Sivan Shamai, Yael Sofer, Nir Lubezky, Yaacov Goykhman, Guy Lahat, Ido Wolf, Sharon Pelles, Asaf Aizic, Arye Blachar, Ravit Geva
Publikováno v:
Biomedicines, Vol 11, Iss 2, p 407 (2023)
The objective of this study was to determine the prognostic value of lymph node (LN) involvement and the LN ratio (LNR) and their effect on recurrence rates and survival in patients with pancreatic neuroendocrine tumors (PNETs) undergoing surgery. Th
Externí odkaz:
https://doaj.org/article/709360edc7fa4272b9ccfd9971c2b745
Autor:
Yonatan Lessing, Niv Pencovich, Nadav Nevo, Nir Lubezky, Yaacov Goykhman, Richard Nakache, Guy Lahat, Joseph M. Klausner, Ido Nachmany
Publikováno v:
World Journal of Surgical Oncology, Vol 17, Iss 1, Pp 1-7 (2019)
Abstract Background Reoperation following PD is a surrogate marker for a complex post-operative course and may lead to devastating consequences. We evaluate the indications for early reoperation following PD and analyze its effect on short- and long-
Externí odkaz:
https://doaj.org/article/6469b66720984e03afe34bf36cb0990e
Autor:
Ayelet Grupper, Yoel Angel, Aharon Baruch, Idit F. Schwartz, Doron Schwartz, Richard Nakache, Yaacov Goykhman, Paulina Katz, Ido Nachmany, Nir Lubezky, Talia Weinstein, Moshe Shashar, Orit Kliuk Ben-Bassat, Shlomo Berliner, Ori Rogowski, David Zeltser, Itzhak Shapira, Shani Shenhar-Tsarfaty
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-11 (2019)
Abstract Background Only few studies of living kidney donors have included controls that were similarly healthy, including excellent kidney function. Methods In this study, we aimed to estimate long term metabolic and renal outcome in a cohort of 211
Externí odkaz:
https://doaj.org/article/ad47f9d9704c491ba3dd478720d12f48
Autor:
Ayelet Grupper, Liane Rabinowich, Merav Ben-Yehoyada, Eugene Katchman, Roni Baruch, Tal Freund, David Hagin, Shani Ben Shlomo, Doron Schwartz, Idit F. Schwartz, Moshe Shashar, Orit Kliuk-Ben Bassat, Tami Halperin, Dan Turner, Esther Saiag, Yaacov Goykhman, Oren Shibolet, Sharon Levy, Inbal Houri, Helena Katchman
Publikováno v:
Transplantation Proceedings. 54:1439-1445
Most solid organ transplant recipients did not develop an appreciable serologic response after 2 doses of the mRNA SARS-CoV-2 vaccine.We analyzed the humoral response after a third dose of the BNT162b2 vaccine in 130 kidney transplant recipients, com
Autor:
Lubezky, Yossi Maman, Yaacov Goykhman, Oz Yakir, Alex Barenboim, Ravit Geva, Sharon Peles-Avraham, Ido Wolf, Joseph M. Klausner, Guy Lahat, Nir
Publikováno v:
Cancers; Volume 15; Issue 11; Pages: 3049
Background: The recommended treatment for resectable pancreatic cancer (PC) is resection followed by adjuvant FOLFIRINOX. We assessed the proportion of patients that managed to complete the 12 courses of adjuvant FOLFIRINOX and compared their outcome
Autor:
Roni Baruch, Nir Lubezky, Ayelet Rishpon, Roie Tzadok, Ayelet Grupper, Yaacov Goykhman, Gila Isman, Esther Ovdat
Publikováno v:
Transplantation Proceedings. 53:2369-2376
Background Organ transplant recipients are at increased risk of nonmelanotic skin cancers (NMSC). Scarce data exist regarding secondary malignancies developing post–simultaneous pancreas-kidney (SPK) transplantations. Our aim was to assess long-ter
Autor:
Ayelet Grupper, Aviad Rabinowich, Idan Ben Shabat, Roie Tzadok, Doron Schwartz, Idit F. Schwartz, Yaacov Goykhman, Orit Kliuk Ben-Bassat, Roni Baruch, Moshe Shashar, Keren Cohen-Hagai, Helena Katchman
Publikováno v:
American journal of nephrology. 53(8-9)
Introduction: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality after kidney transplantation. Metabolic syndrome is common in renal transplant recipients and is associated with increased CVD risk in those patients. Nonalcoh
Autor:
Helena Katchman, Ido Nachmany, Liane Rabinowich, Sharon Levy, N. Gotlieb, Yaacov Goykhman, Oren Shibolet, O. Gilad, P. Katz, Nir Lubezky
Publikováno v:
Transplantation Proceedings. 53:221-227
Background Mammalian target of rapamycin (mTOR) inhibitors following liver transplantation (LT) are used to minimize calcineurin inhibitor (CNI)-related nephrotoxicity. Data about metabolic effects of mTOR inhibitors are still limited. Aim This study